Sign Up For FREE
Health After 50 Alerts!

We value your privacy and will never rent your email address

Health After 50

New Treatment Option for Heart Failure Reduces Risk of Hospitalization

Comments (0)

If you have heart failure, there is a new option for lowering your risk of a hospital stay.

A drug called ivabradine (Corlanor) can help prevent hospitalizations in certain people with heart failure—namely, those whose heart rate remains high despite standard treatment with beta-blockers. The U.S. Food and Drug Administration had given the drug an “expedited” review, which speeds the approval process for drugs that may offer a significant advantage over existing therapies.

The approval was based on a clinical trial of 6,500 patients who had been hospitalized in the past year for heart failure and experienced a stubbornly high resting heart rate (at least 70 beats per minute). Over two years, patients given ivabradine along with standard therapy were 26 percent less likely to be hospitalized for worsening heart failure, versus patients given a placebo.

Ivabradine works by slowing the heart rate, which helps lessen strain on the heart. That’s also the source of its most common side effect: bradycardia, an abnormally slow heart rate. About 10 percent of patients in the clinical trial developed bradycardia, while anywhere from 2 to 9 percent developed high blood pressure, atrial fibrillation or temporary vision disturbances.

If you have a persistently high heart rate, your doctor might try adding ivabradine to your regimen. Just be aware of possible signs that the drug is causing problems, including dizziness, fatigue, a racing or pounding heartbeat, or chest pressure. 


Posted in Heart Health on March 25, 2016

Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Health After 50 Disclaimer

Notify Me

Would you like us to inform you when we post new Heart Health Health Alerts?

Post a Comment


Health After 50 Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Scientific American Health After 50 or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.

Post a Comment

Already a subscriber?


Forgot your password?

New to Health After 50?

Register to submit your comments.

(example: [email protected])


Forgot Password?

Atrial Fibrillation:
The Latest Management Strategies

Atrial Fibrillation (AF) can be a debilitating even deadly condition -- but it doesn't have to be this way. There are many steps you can take to manage your AF BEFORE it seriously impacts your quality of life. If you're looking for straightforward, informed answers to your most important questions about living with AF, our comprehensive new report can help. Written by Hugh Calkins, M.D., and Ronald Berger, M.D., Ph.D., experts in the diagnosis and treatment of arrhythmias, Atrial Fibrillation: The Latest Management Strategies explains the full-range of your anticoagulation therapy choices . . . the benefits of rate versus rhythm control for AF . . . surgical ablation of AF . . . the differences among paroxysmal AF, persistent AF, and chronic AF . . . and much more.

Read more or Order

2016 Coronary Heart Disease White Paper

The Coronary Heart Disease White Paper reports on the latest life-saving advances for your heart health, to help you prevent or treat coronary heart disease. Topics include preventing first heart attacks; heart attack recovery and its effects on your overall lifestyle and health; preventing a second heart attack; angina; cardiac arrhythmias; and congestive heart failure.

Read more or Order

Health Topic Pages